HB 4947 Michigan House · 2025-2026 Regular Session

Health: pharmaceuticals; manufacturers of products containing ephedrine or pseudoephedrine; require to participate in a national logging system. Amends secs. 7340 & 7340a of 1978 PA 368 (MCL 333.7340 & 333.7340a).

HB 4947 requires pharmaceutical manufacturers selling products containing ephedrine or pseudoephedrine in Michigan to join a national real-time tracking system (NPLEx) starting June 1, 2026. This bill directly affects manufacturers of these products, mandating they participate in the system to log retail sales. The key mechanism is the NPLEx, which tracks purchases to prevent diversion into methamphetamine production, with retailers already required to use it for sales. The bill amends Michigan’s Public Health Code (sections 7340a(6)) to extend this tracking requirement to manufacturers, not just retailers.

Bill status passed both 4 of 5 stages cleared

Introduction

Sep 2025

Committee Review

Jan 2026

House Passage

Jan 2026

Senate Passage

Jan 2026

Governor

Introduced Sep 16, 2025 Last action Jan 21, 2026

Maddy AI version diff · 1 comparison

What changed between versions

House Introduced Bill → As Passed by the House · 3 edits · Jan 14, 2026

MINOR

The bill clarifies that the sale of ephedrine and pseudoephedrine products via mail, internet, or phone is prohibited unless shipped directly to the buyer, aligning online sales with existing physical store restrictions. It also reorganizes the list of exemptions to ensure pediatric products and liquid formulations are clearly excluded from these restrictions, while maintaining penalties for violations.

Scope change

The scope was expanded to explicitly cover and restrict online and remote sales methods (mail, internet, telephone) that were not clearly addressed in the original text, ensuring these channels are held to the same standards as in-person transactions.

REQUIREMENT

Prohibits the sale of ephedrine or pseudoephedrine products through mail, internet, telephone, or other electronic means unless the product is shipped directly to the purchaser.

Added a requirement that retail sales conducted under this section must comply with 21 USC 830 and other applicable federal laws.

SCOPE

Reordered and clarified the list of exemptions to explicitly include pediatric products for children under 12 and liquid pseudoephedrine products where it is not the only active ingredient.

Floor votes · House Jan 14, 2026

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jan 21, 2026

Committee

REFERRED TO COMMITTEE ON HEALTH POLICY

upper

Jan 21, 2026

Upper · Passed

PASSED BY HOUSE WITH IMMEDIATE EFFECT

upper

Jan 14, 2026

Lower · Passed

passed; given immediate effect Roll Call #8 Yeas 87 Nays 22 Excused 0 Not Voting 1

lower

Nov 12, 2025

Committee

referred to second reading

lower

Nov 12, 2025

Lower · Passed

reported with recommendation without amendment

lower

Sep 16, 2025

Committee

referred to Committee on Judiciary

lower

Sep 16, 2025

Introduced

introduced by Representative Rep. Brian BeGole

lower

1 primary · 10 co-sponsors